Histamine-Induced Conjunctivitis and Breakdown of Blood–Tear Barrier in Dogs: A Model for Ocular Pharmacology and Therapeutics

Conjunctival inflammation disturbs the blood–tear barrier and thus affects the tear film stability and composition. We aimed to develop a non-invasive and reliable method to induce conjunctivitis in dogs, a large animal model for translational work on ocular surface disease in humans. Six beagle dog...

Full description

Bibliographic Details
Main Authors: Lionel Sebbag, Rachel A. Allbaugh, Amanda Weaver, Yeon-Jung Seo, Jonathan P. Mochel
Format: Article
Language:English
Published: Frontiers Media S.A. 2019-07-01
Series:Frontiers in Pharmacology
Subjects:
dog
Online Access:https://www.frontiersin.org/article/10.3389/fphar.2019.00752/full
id doaj-1dde81286dcc4e5c88086f6937a83620
record_format Article
spelling doaj-1dde81286dcc4e5c88086f6937a836202020-11-25T00:35:43ZengFrontiers Media S.A.Frontiers in Pharmacology1663-98122019-07-011010.3389/fphar.2019.00752461206Histamine-Induced Conjunctivitis and Breakdown of Blood–Tear Barrier in Dogs: A Model for Ocular Pharmacology and TherapeuticsLionel Sebbag0Lionel Sebbag1Rachel A. Allbaugh2Amanda Weaver3Yeon-Jung Seo4Jonathan P. Mochel5Department of Veterinary Clinical Sciences, College of Veterinary Medicine, Iowa State University, Ames, IA, United StatesDepartment of Biomedical Sciences, College of Veterinary Medicine, Iowa State University, Ames, IA, United StatesDepartment of Veterinary Clinical Sciences, College of Veterinary Medicine, Iowa State University, Ames, IA, United StatesLloyd Veterinary Medical Center, College of Veterinary Medicine, Iowa State University, Ames, IA, United StatesDepartment of Biomedical Sciences, College of Veterinary Medicine, Iowa State University, Ames, IA, United StatesDepartment of Biomedical Sciences, College of Veterinary Medicine, Iowa State University, Ames, IA, United StatesConjunctival inflammation disturbs the blood–tear barrier and thus affects the tear film stability and composition. We aimed to develop a non-invasive and reliable method to induce conjunctivitis in dogs, a large animal model for translational work on ocular surface disease in humans. Six beagle dogs underwent a randomized, vehicle-controlled, balanced crossover trial—on six separate days, one eye received topical artificial tears (vehicle), while the other eye received one of six concentrations of histamine solution (0.005–500 mg/ml). At sequential times after eyedrop administration, a conjunctivitis score was given to each eye based on the degree of palpebral and bulbar conjunctival hyperemia and chemosis, ocular pruritus, and discharge. Total protein content (TPC) and serum albumin were quantified in tear fluid at baseline and 20 min. Additionally, 13 dogs presenting for various ophthalmic diseases with associated conjunctivitis were examined. Experimentally induced conjunctivitis developed rapidly (<1 min) following topical histamine administration and lasted for 1–3 h (four lowest doses) to 6–8 h (two highest doses). The severity of conjunctivitis was dose-dependent. Histamine was overall well tolerated, although transient blepharitis, aqueous flare, and ocular hypertension occurred in a few dogs receiving histamine ≥375 mg/ml. TPC and serum albumin levels increased in tears of eyes receiving histamine ≥1.0 mg/ml, being significantly higher than vehicle and baseline in eyes receiving histamine ≥375 mg/ml. Lacrimal albumin levels were also increased in 13 dogs with naturally acquired conjunctivitis, up 2.7–14.9 fold compared to contralateral healthy eyes. Histamine-induced conjunctivitis represents a robust model for translational work on the ocular surface given the low cost, non-invasiveness, self-resolving nature, ability to adjust the duration and severity of the disease, and shared features with naturally occurring ocular diseases. Histamine solutions of 1, 10, and 375 mg/ml induce mild, moderate, and severe conjunctivitis in dogs, respectively. Leakage of serum albumin in tear fluid of eyes with conjunctivitis suggests a breakdown of the blood–tear barrier.https://www.frontiersin.org/article/10.3389/fphar.2019.00752/fullalbuminblood–tear barrierconjunctivitisdoghistamineocular surface
collection DOAJ
language English
format Article
sources DOAJ
author Lionel Sebbag
Lionel Sebbag
Rachel A. Allbaugh
Amanda Weaver
Yeon-Jung Seo
Jonathan P. Mochel
spellingShingle Lionel Sebbag
Lionel Sebbag
Rachel A. Allbaugh
Amanda Weaver
Yeon-Jung Seo
Jonathan P. Mochel
Histamine-Induced Conjunctivitis and Breakdown of Blood–Tear Barrier in Dogs: A Model for Ocular Pharmacology and Therapeutics
Frontiers in Pharmacology
albumin
blood–tear barrier
conjunctivitis
dog
histamine
ocular surface
author_facet Lionel Sebbag
Lionel Sebbag
Rachel A. Allbaugh
Amanda Weaver
Yeon-Jung Seo
Jonathan P. Mochel
author_sort Lionel Sebbag
title Histamine-Induced Conjunctivitis and Breakdown of Blood–Tear Barrier in Dogs: A Model for Ocular Pharmacology and Therapeutics
title_short Histamine-Induced Conjunctivitis and Breakdown of Blood–Tear Barrier in Dogs: A Model for Ocular Pharmacology and Therapeutics
title_full Histamine-Induced Conjunctivitis and Breakdown of Blood–Tear Barrier in Dogs: A Model for Ocular Pharmacology and Therapeutics
title_fullStr Histamine-Induced Conjunctivitis and Breakdown of Blood–Tear Barrier in Dogs: A Model for Ocular Pharmacology and Therapeutics
title_full_unstemmed Histamine-Induced Conjunctivitis and Breakdown of Blood–Tear Barrier in Dogs: A Model for Ocular Pharmacology and Therapeutics
title_sort histamine-induced conjunctivitis and breakdown of blood–tear barrier in dogs: a model for ocular pharmacology and therapeutics
publisher Frontiers Media S.A.
series Frontiers in Pharmacology
issn 1663-9812
publishDate 2019-07-01
description Conjunctival inflammation disturbs the blood–tear barrier and thus affects the tear film stability and composition. We aimed to develop a non-invasive and reliable method to induce conjunctivitis in dogs, a large animal model for translational work on ocular surface disease in humans. Six beagle dogs underwent a randomized, vehicle-controlled, balanced crossover trial—on six separate days, one eye received topical artificial tears (vehicle), while the other eye received one of six concentrations of histamine solution (0.005–500 mg/ml). At sequential times after eyedrop administration, a conjunctivitis score was given to each eye based on the degree of palpebral and bulbar conjunctival hyperemia and chemosis, ocular pruritus, and discharge. Total protein content (TPC) and serum albumin were quantified in tear fluid at baseline and 20 min. Additionally, 13 dogs presenting for various ophthalmic diseases with associated conjunctivitis were examined. Experimentally induced conjunctivitis developed rapidly (<1 min) following topical histamine administration and lasted for 1–3 h (four lowest doses) to 6–8 h (two highest doses). The severity of conjunctivitis was dose-dependent. Histamine was overall well tolerated, although transient blepharitis, aqueous flare, and ocular hypertension occurred in a few dogs receiving histamine ≥375 mg/ml. TPC and serum albumin levels increased in tears of eyes receiving histamine ≥1.0 mg/ml, being significantly higher than vehicle and baseline in eyes receiving histamine ≥375 mg/ml. Lacrimal albumin levels were also increased in 13 dogs with naturally acquired conjunctivitis, up 2.7–14.9 fold compared to contralateral healthy eyes. Histamine-induced conjunctivitis represents a robust model for translational work on the ocular surface given the low cost, non-invasiveness, self-resolving nature, ability to adjust the duration and severity of the disease, and shared features with naturally occurring ocular diseases. Histamine solutions of 1, 10, and 375 mg/ml induce mild, moderate, and severe conjunctivitis in dogs, respectively. Leakage of serum albumin in tear fluid of eyes with conjunctivitis suggests a breakdown of the blood–tear barrier.
topic albumin
blood–tear barrier
conjunctivitis
dog
histamine
ocular surface
url https://www.frontiersin.org/article/10.3389/fphar.2019.00752/full
work_keys_str_mv AT lionelsebbag histamineinducedconjunctivitisandbreakdownofbloodtearbarrierindogsamodelforocularpharmacologyandtherapeutics
AT lionelsebbag histamineinducedconjunctivitisandbreakdownofbloodtearbarrierindogsamodelforocularpharmacologyandtherapeutics
AT rachelaallbaugh histamineinducedconjunctivitisandbreakdownofbloodtearbarrierindogsamodelforocularpharmacologyandtherapeutics
AT amandaweaver histamineinducedconjunctivitisandbreakdownofbloodtearbarrierindogsamodelforocularpharmacologyandtherapeutics
AT yeonjungseo histamineinducedconjunctivitisandbreakdownofbloodtearbarrierindogsamodelforocularpharmacologyandtherapeutics
AT jonathanpmochel histamineinducedconjunctivitisandbreakdownofbloodtearbarrierindogsamodelforocularpharmacologyandtherapeutics
_version_ 1725307878740328448